Fibromyalgia and mortality: a systematic review and meta-analysis

Objective To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis.Methods The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify stu...

Full description

Bibliographic Details
Main Authors: Roni Peleg, Yulia Treister-Goltzman
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003005.full
_version_ 1797640094115430400
author Roni Peleg
Yulia Treister-Goltzman
author_facet Roni Peleg
Yulia Treister-Goltzman
author_sort Roni Peleg
collection DOAJ
description Objective To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis.Methods The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify studies that addressed an association between fibromyalgia and mortality. Original papers that assessed associations between fibromyalgia and mortality (all or specific causes) and provided an effect measure (hazard ratio (HR), standardised mortality ratio (SMR), odds ratio (OR)) quantifying the relationship between fibromyalgia and mortality were included in the systematic review. Of 557 papers that were initially identified using the search words, 8 papers were considered eligible for the systematic review and meta-analysis. We used a Newcastle-Ottawa scale to assess the risk of bias in the studies.Results The total fibromyalgia group included 188 751 patients. An increased HR was found for all-cause mortality (HR 1.27, 95% CI 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. There was a borderline increased SMR for accidents (SMR 1.95, 95% CI 0.97 to 3.92), an increased risk for mortality from infections (SMR 1.66, 95% CI 1.15 to 2.38), and suicide (SMR 3.37, 95% CI 1.52 to 7.50), and a decreased mortality rate for cancer (SMR 0.82, 95% CI 0.69 to 0.97). The studies showed significant heterogeneity.Conclusions These potential associations indicate that fibromyalgia should be taken seriously, with a special focus on screening for suicidal ideation, accident prevention, and the prevention and treatment of infections.
first_indexed 2024-03-11T13:26:53Z
format Article
id doaj.art-da3daca700574788888be62e89d2d92b
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-03-11T13:26:53Z
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-da3daca700574788888be62e89d2d92b2023-11-03T06:25:07ZengBMJ Publishing GroupRMD Open2056-59332023-07-019310.1136/rmdopen-2023-003005Fibromyalgia and mortality: a systematic review and meta-analysisRoni Peleg0Yulia Treister-Goltzman11 Department of Family Medicine and Siaal Research Center for Family Practice and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel1 Department of Family Medicine and Siaal Research Center for Family Practice and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, IsraelObjective To conduct a systematic review of the literature on the association between fibromyalgia and mortality and to pool the results in a meta-analysis.Methods The authors searched the PubMed, Scopus, and Web of Science databases using the key words ‘fibromyalgia’ and ‘mortality’ to identify studies that addressed an association between fibromyalgia and mortality. Original papers that assessed associations between fibromyalgia and mortality (all or specific causes) and provided an effect measure (hazard ratio (HR), standardised mortality ratio (SMR), odds ratio (OR)) quantifying the relationship between fibromyalgia and mortality were included in the systematic review. Of 557 papers that were initially identified using the search words, 8 papers were considered eligible for the systematic review and meta-analysis. We used a Newcastle-Ottawa scale to assess the risk of bias in the studies.Results The total fibromyalgia group included 188 751 patients. An increased HR was found for all-cause mortality (HR 1.27, 95% CI 1.04 to 1.51), but not for the subgroup diagnosed by the 1990 criteria. There was a borderline increased SMR for accidents (SMR 1.95, 95% CI 0.97 to 3.92), an increased risk for mortality from infections (SMR 1.66, 95% CI 1.15 to 2.38), and suicide (SMR 3.37, 95% CI 1.52 to 7.50), and a decreased mortality rate for cancer (SMR 0.82, 95% CI 0.69 to 0.97). The studies showed significant heterogeneity.Conclusions These potential associations indicate that fibromyalgia should be taken seriously, with a special focus on screening for suicidal ideation, accident prevention, and the prevention and treatment of infections.https://rmdopen.bmj.com/content/9/3/e003005.full
spellingShingle Roni Peleg
Yulia Treister-Goltzman
Fibromyalgia and mortality: a systematic review and meta-analysis
RMD Open
title Fibromyalgia and mortality: a systematic review and meta-analysis
title_full Fibromyalgia and mortality: a systematic review and meta-analysis
title_fullStr Fibromyalgia and mortality: a systematic review and meta-analysis
title_full_unstemmed Fibromyalgia and mortality: a systematic review and meta-analysis
title_short Fibromyalgia and mortality: a systematic review and meta-analysis
title_sort fibromyalgia and mortality a systematic review and meta analysis
url https://rmdopen.bmj.com/content/9/3/e003005.full
work_keys_str_mv AT ronipeleg fibromyalgiaandmortalityasystematicreviewandmetaanalysis
AT yuliatreistergoltzman fibromyalgiaandmortalityasystematicreviewandmetaanalysis